ICU Medical, Inc. (ICUI): Price and Financial Metrics
ICU Medical, Inc. (ICUI)
Today's Latest Price: $215.47 USD
Updated Jan 15 4:00pm
Add ICUI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 185 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
ICUI Stock Summary
- The ratio of debt to operating expenses for Icu Medical Inc is higher than it is for about only 0.53% of US stocks.
- With a year-over-year growth in debt of -100%, Icu Medical Inc's debt growth rate surpasses only 0% of about US stocks.
- The volatility of Icu Medical Inc's share price is greater than that of just 6.42% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Icu Medical Inc, a group of peers worth examining would be SSTK, GMED, ITI, ATRI, and CCF.
- Visit ICUI's SEC page to see the company's official filings. To visit the company's web site, go to www.icumed.com.
ICUI Stock Price Chart Interactive Chart >
ICUI Price/Volume Stats
| Current price | $215.47 | 52-week high | $236.51 |
| Prev. close | $221.38 | 52-week low | $158.01 |
| Day low | $214.90 | Volume | 107,200 |
| Day high | $223.54 | Avg. volume | 187,750 |
| 50-day MA | $201.26 | Dividend yield | N/A |
| 200-day MA | $194.83 | Market Cap | 4.52B |
ICU Medical, Inc. (ICUI) Company Bio
ICU Medical develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. The company was founded in 1984 and is based in San Clemente, California.
ICUI Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $215.47 | $61.75 | -72% |
Below please find a table outlining a discounted cash flow forecast for ICUI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Icu Medical Inc ranked in the 24th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Icu Medical Inc ended up being:
- The company's balance sheet shows it gets 100% of its capital from equity, and 0% of its capital from debt. Notably, its equity weight is greater than 95.79% of US equities in the Healthcare sector yielding a positive free cash flow.
- The business' balance sheet suggests that 0% of the company's capital is sourced from debt; this is greater than only 0.05% of the free cash flow producing stocks we're observing.
- ICUI's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 59.75% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -73% |
| 1% | -72% |
| 2% | -72% |
| 3% | -72% |
| 4% | -72% |
| 5% | -71% |
Want more companies with a valuation profile/forecast similar to that of Icu Medical Inc? See DHR, ILMN, WAT, CDNA, and CNC.
Loading social stream, please wait...